The Enterprise Value as of November 2025 (TTM) for Advanced Oncotherapy plc (AVO.L) is 58.59M

According to Advanced Oncotherapy plc’s latest financial reports and current stock price. The company's current Enterprise Value is 58.59M. This represents a change of 39.25% compared to the average of 42.07M of the last 4 quarters.

Advanced Oncotherapy plc (AVO.L) Historical Enterprise Value (quarterly & annually)

How has AVO.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Advanced Oncotherapy plc over the last ten years is 15.57M. The current 58.59M Enterprise Value has changed 37.53% with respect to the historical average. Over the past ten years (40 quarters), AVO.L's Enterprise Value was at its highest in in the June 2021 quarter at 59.29M. The Enterprise Value was at its lowest in in the June 2015 quarter at -13723584.57.

Advanced Oncotherapy plc (AVO.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Advanced Oncotherapy plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Advanced Oncotherapy plc (AVO.L) Average Enterprise Value

How has AVO.L Enterprise Value performed in the past?

The current Enterprise Value of Advanced Oncotherapy plc (AVO.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Advanced Oncotherapy plc (AVO.L) Enterprise Value vs. Peers

How is AVO.L’s Enterprise Value compared to its peers?

Advanced Oncotherapy plc’s Enterprise Value is greater than MGC Pharmaceuticals Limited (27.93M), greater than Induction Healthcare Group PLC (5.52M), greater than Celadon Pharmaceuticals Plc (12.68M), greater than BiVictriX Therapeutics Plc (5.24M), greater than Synairgen plc (1.06M), greater than Belluscura plc (3.31M), greater than Argent BioPharma Limited (8.73M), greater than NetScientific plc (16.55M), greater than Kanabo Group Plc (13.96K), greater than Cel AI PLC (601.50K),

Build a custom stock screener for Advanced Oncotherapy plc (AVO.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advanced Oncotherapy plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advanced Oncotherapy plc (AVO.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advanced Oncotherapy plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.